secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001437749-22-025648
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q2 revenue up 64% but GAAP EPS down 65%; non-GAAP AOI up 55%
----------------------------------------------------------------------

- Revenue $58.7M (+64% YoY); organic growth 12% (18% constant currency). Net income $1.3M (-65%), diluted EPS $0.24.
- GAAP operating income $4.0M (-5%); non-GAAP AOI $15.5M (+55%), $2.88 per diluted share.
- Segments: Clinical Genomics $18.4M (+27% seq), Sterilization $17.0M (+21% org), Biopharma $12.1M (+15% org), Calibration $11.2M flat.
- H1 revenue $109.2M (+54%); GAAP operating loss $0.6M, net loss $0.1M; non-GAAP AOI $21.6M (+13%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774922025648/0001437749-22-025648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774922025648/mlab20221102_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-025648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer